Results 11 to 20 of about 6,007,439 (376)

Adverse event reporting in studies of penetrating acupuncture during pregnancy: a systematic review [PDF]

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2015
Background - Acupuncture within pregnancy has frequently been investigated, often with finding this to be more effective than standard care. However, the adverse event severity, types and occurrence are unclear.
Carlsson   +39 more
core   +3 more sources

Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea [PDF]

open access: yesEpidemiology and Health, 2022
OBJECTIVES In Korea, a national coronavirus disease 2019 (COVID-19) vaccination program was implemented, including 4 vaccines against COVID-19. A text messaging-based survey, in addition to a passive adverse event reporting system, was launched to ...
Yunhyung Kwon   +7 more
doaj   +1 more source

Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea [PDF]

open access: yesOsong Public Health and Research Perspectives, 2022
Objectives This study aimed to disseminate information on coronavirus disease 2019 (COVID-19) vaccine safety among adolescents aged 12 to 17 years in the Republic of Korea.
Seontae Kim   +4 more
doaj   +1 more source

Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years [PDF]

open access: yesOsong Public Health and Research Perspectives, 2022
Objectives This study aimed to identify potential safety signals and adverse events following the primary Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccination series among children and adolescents aged 5 to 17 years in the Republic of Korea ...
Seontae Kim   +5 more
doaj   +1 more source

COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021 [PDF]

open access: yesOsong Public Health and Research Perspectives, 2021
Objectives This study aimed to present data on reported adverse events following coronavirus disease 2019 (COVID-19) vaccination in Republic of Korea from February 26 to October 31, 2021, and to determine whether any significant patterns emerged from an ...
Insob Hwang   +4 more
doaj   +1 more source

The incidence and clinical characteristics of myocarditis and pericarditis following mRNA-based COVID-19 vaccination in Republic of Korea adolescents from July 2021 to September 2022 [PDF]

open access: yesOsong Public Health and Research Perspectives, 2023
Objectives Age-specific information regarding myocarditis/pericarditis in adolescents following mRNA-based coronavirus disease 2019 (COVID-19) vaccination in Asia remains insufficient. This study investigated the incidence and clinical characteristics of
Ju-Young Sim   +2 more
doaj   +1 more source

Adverse Event [PDF]

open access: yesDefinitions, 2020
Objective: To describe the characteristics of adverse events related to the main antibiotics used in pediatrics reported to VigiMed in Brazil, from 2018 to 2025. Methods: This is a retrospective ecological quantitative study, in which data collected from
Sarah Silvestre Borges   +7 more
openaire   +2 more sources

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for etrasimod [PDF]

open access: yesFrontiers in Pharmacology
ObjectiveTo characterize the post-marketing safety profile of etrasimod using the latest data from the FDA Adverse Event Reporting System (FAERS), and to provide a comparative analysis versus other sphingosine-1-phosphate (S1P) receptor modulators ...
Yingxiu Wu   +4 more
doaj   +2 more sources

Safety profile of inactivated COVID-19 vaccine in indonesian adults

open access: yesVaccine: X, 2023
Background: Vaccines are urgently needed to handle the morbidity and mortality of the COVID-19 pandemic in Indonesia. The inactivated vaccine is widely used in Indonesia's national immunization program due to its eligibility of stock, easier to transport,
Hindra Irawan Satari   +7 more
doaj   +1 more source

A real‐world pharmacovigilance study of FDA adverse event reporting system events for sildenafil

open access: yesAndrology, 2023
Sildenafil, a selective inhibitor of phosphodiesterase type 5 (PDE5), is widely used for the treatment of erectile dysfunction (ED). However, the safety profile of sildenafil, including adverse event (AEs), requires comprehensive evaluation.
Y. Wang   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy